Study about the efficacy of metformin to immune function in cancer patients.

Not Applicable

• Conditions: cancer and sarcoma

• Registration Number: JPRN-UMIN000014689
• Lead Sponsor: Okayama University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-07-28
• Study Completion: 2019-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who have received insulin therapy for diabetes mellitus. 2. Subjects who have the previous medical history of lactic acidosis. 3. Subjects who have received hemodialysis. 4. Subjects who have serious hepatic dysfunction. 5. Subjects who have the previous medical history of shock status, heart failure, cardiac infarction, pulmonary infarction and hypoxia. 6. Subjects who have drinking habit. 7. Subjects who are dehydration, 8. Subjects who have the previous medical history of severe ketosis, diabetic coma and type 1 diabetes. . 9. Subjects who have severe infection and serious trauma. 10. Subjects who are malnutrition, starvation, adrenal insufficiency and pituitary gland dysfunction. 11. Pregnant wouman 12. Subjects who are allergic to medicines. 13. Subjects who have been enrolled in the other clinical trials within last 4 months before the administration of metformin and administered any investigational new drugs. 14. Other subjects who are judged to be ineligible in this trial by the investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified